Member Info for neilrich3

David Franks Chief Human Resources Officer, a new member of the Executive Management, an interesting appointment, his Linkedin is a good read. Wondering whether David has been brought on board to handle the HR aspect of a major acquisition? Novacyt already have a Group HR Manager as part of the Executive Management.

Although a grand title, Group Clinical Performance Director, does not necessarily mean a member of the board or the executive management.

My concern is Guillermo Raimondo, the Chief Commercial Officer, what's he doing within South America and is he leading a team, or working alone?

Actually....having watched for the 4th time, pause at 4:58, there's a Q32 and a Q16 in the background.

Plus the box has Q32 ProMate written on the side.

No, problem. Pause the video at 5:06 and zoom in, that looks like a template for the Q32.

https://www.ft.com/video/2c970196-2db6-4c1d-ac7b-cea05aa8feb9

Primerdesign in use at 5:15

https://www.washingtonpost.com/world/2021/04/29/india-surge-variant-genetic-sequencing/

Iceland 78.8% of positive samples
Australia 60.3%
Denmark 20.2%
USA 1%
India 0.06%

Many Countries have no idea as to the prevalence of mutations, yet some would have you believe that testing is over.

Check out the google reviews for the company offering £45 PCR....

Horrible experience, will call themselves clever cons. They charge more to deliver travel test kit, but you find out later they insert in T&C no responsibility for late processing of the test beyond the maximum 72 hours permissible. They have no contact numbers, reply to emails the following day through human automated replays (our T&C). Most infuriating is they won’t accept partial refund to avoid processing of late (useless) test result. Among the number of COVID testing services, this is by far the worst of all that I will never use again or recommend to anyone. Sadly, some have principles or morals to use the pandemic for extracting money of customers for no useful service in return.

Out Right a Bunch of Thief. Not sure how this company got "Gov Approved". Legit took my money and didn't send me the day 2 and day 8 test kit. They'll place the whole country in jeopardy and in risk of a new variant. As long as they can profit from it. They legit even refused to give a refund which I needed so I could afford to order else where. Can't believe a UK company could operate like this.

Appalling service. DO NOT USE. I paid for a next day test and received an 'unclear' result. Whilst I acknowledge this can happen, we should have been offered another test in order to clarify the result. When I arranged this test, I also paid for a day 2 and 8 test for reentering the UK. Whilst their 'customer service' e mail was quick at responding why my result was 'unclear' nobody responded at all about a refund of the other £159 paid for my Day 2 and 8 tests. The worst kind of, 'we'll take your money but dont care what sort of service we offer' type company. Sort it out Assured Screening and Honeyman Group.

https://pbs.twimg.com/media/E0RANcwXEAEjjH0?format=jpg&name=medium

http://www.healthdata.org/node/8584

AZN has the worst efficacy against the P1 variant.

https://twitter.com/NovacytGroup/status/1372488458195861505

Tweet from 18/03 confirming detection of the Breton variant.

Novacyt confirmed at the time that our PCR detects the Breton variant.

More to it than simply placing a Novacyt label upon an Avacta Test, the RNS clearly states 'working with a partner to develop this test' which suggests that Novacyt's input has been pivotal. LFT is nothing new to Novacyt, they have some previous history, nothing announced previously, because as we know GM likes to play his cards close to his chest.

Who's the partner? Hoping that it might be Astra Zeneca?

PathFlow® SARS-CoV-2 Antigen is a professional and home use LFT for the detection of SARS-CoV-2 antigens using non-invasive anterior nasal swab samples to provide a result in approximately 15 minutes. Novacyt has been working with a partner to develop this test, which is able to detect the virus regardless of current known mutations.

https://twitter.com/CapitalPmh/status/1386288592885059584

....Finally wrt valuation, assuming #NCYT delivers 2022 sales of say €125m (SP Angel at €127m), then the stock looks to be a steal at 440p - trading on <5x EV/EBITDA (ex cash)

So much more than the UK though...it's how do you keep the world moving? Of course the answer is the same, but the market for NCYT products is so big that I can't get my head around it.

I'd expect further developments/news soon with an International Operational update.

Have to wonder whether GM has something else up his sleeve, perhaps some international sales news pending that could not be announced Today, a major new international deal agreed in principal, something that could be announced in the weeks ahead. I'd imagine that there shall be much international interest in the new products announced Today.

Business Development Manager (Pharma and Biotech)
Home Based (with time spent at the Southampton and Camberley offices and international travel)

About Us

We are Novacyt, a rapidly growing diagnostics group specialising in infectious diseases. We have a number of successful brands and serve a large global customer base, from hospitals to large corporates.

Under our brand, Primerdesign, we have delivered exceptional products to combat formidable challenges. We developed the world's first swine flu detection kit, played an important part in uncovering the UK's horse meat scandal and are currently producing high–performing detection kits to support the fight against COVID–19.

We're currently looking for a Business Development Manager to join us and create opportunities for our solutions portfolio within the Pharma and Biotech space.

The Benefits

– Competitive salary
– Private medical insurance
– Group pension scheme
– Life assurance
– 25 days' holiday per annum
– The ability to buy and sell annual leave
– Cycle scheme
– Refer a friend scheme

If you have a background of sales success within the Pharma sector, this is the ideal role in which to utilise your existing knowledge and skills to advance your career and support our thriving organisation in achieving our ambitious targets.

We have a history of leading from the front when it comes to tackling some of the world's biggest healthcare challenges, and today it's no different. We have an outstanding portfolio of products and we need the right people to promote these within the market.

So, if you are ready for a career–defining role where you can make a difference to healthcare whilst advancing professionally, this is the role you've been waiting for.

The Role

As a Business Development Manager, you will be responsible for creating sales of our product portfolio with particular focus on the development of customised assay solutions for CDx and MDx. This will include high throughput screening solutions and the development of strategic partnerships within this area.

Identifying key stakeholders in targeted organisations, you will utilise them to identify new product development areas that will help us to fulfil our ambitious growth targets.

This home–based role will see you spending some time at our Southampton and Camberley offices and undertaking international travel (when restrictions allow) to develop and deliver on sales targets.

You'll be selling our B2B portfolio of products, undertaking assay development, offering consultancy and creating opportunities for our manufacturing services, OEM and private label portfolio.

Your Role Will Also Involve

– Working with Pharma and Biotech companies and kit manufacturers on kit, product or component sales opportunities
– Developing your pipeline of newly launched products
– Supporting wider group sales teams
– Working with our BDD on long–term and R&D critical opportunities

About You

To be cons

Inquire at sales@attogene.com for bundles for a free q16 or q32 instrument (while supplies last) with the purchase of 50 or more COVID 19 or COVID 19 variant SNP detection Kits.